473: The NIFTY study: a multi-centre randomised double blind placebo controlled trial of nifedipine maintenance tocolysis in fetal fibronectin positive women in threatened preterm labour - 29/12/11
Doi : 10.1016/j.ajog.2011.10.491
Emma Parry 1, Carolien Roos 2, Peter Stone 3, Lynsey Hayward 4, Ben Willem Mol 5, Lesley McCowan 6
1 Auckland District Health Board, Maternal-Fetal Medicine, Auckland, New Zealand
2 Dutch Consortium for Studies in Women's Health and Reproductivity, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands
3 University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand
4 Counties Manukau District Health Board, Obstetrics and Gynaecology, Auckland, New Zealand
5 Dutch consortium AMPHIA trial, Netherlands
6 University of Auckland, Department of Obstetrics and Gynaecology, Auckland, New Zealand
Le texte complet de cet article est disponible en PDF.
Plan
© 2012
Mosby, Inc. Tous droits réservés.
Vol 206 - N° 1S
P. S216 - janvier 2012 Retour au numéro
Article précédent
- 472: Progestogen in twin pregnancies: an individual participant data meta-analysis of randomized trials
- E. Schuit, Sarah Stock, Dwight Rouse, A.C. Lim, Line Rode, Jane Norman, Anwar Nassar, Vicente Serra, C. Andrew Combs, Patrick Rozenberg, Elcin Cetingoz, Christian Briery, Elizabeth Thom, Steve Caritis, Katharina Klein, Ann Tabor, Johnny Awwad, Ihab Usta, Alfredo Perales, Juan Meseguer, Kimberly Maurel, Thomas Garite, Cetin Cam, Ates Karateke, John Morrison, Everett Magann, Rolf H.H. Groenwold, Karel Moons, Anneke Kwee, Ben Willem Mol
- 474: Potential benefits of vaginal delivery on significant morbidity in preterm AGA infants
- Erika F. Werner, Christina S. Han, David Savitz, Anna Sfakianaki, Edmund F. Funai, Heather Lipkind
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?